United Therapeutics (UTHR) Posts Q3 adj.-EPS of $2.98; Raises FY13 Revs Outlook
Tweet Send to a Friend
United Therapeutics (NASDAQ: UTHR) reported Q3 EPS of $2.98, $1.39 better than ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
